Literature DB >> 5315431

An in-vitro model of anesthetic hypertonic hyperpyrexia, halothane--caffeine-induced muscle contractures: prevention of contracture by procainamide.

G E Strobel, C P Bianchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5315431     DOI： 10.1097/00000542-197111000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN： 0003-3022            Impact factor:   7.892


× No keyword cloud information.
  5 in total

1.  Dystrophia myotonica: a multisystem disease.

Authors:  F Y Dalal; E J Bennett; P P Raj; D G Lee
Journal:  Can Anaesth Soc J       Date:  1972-07

2.  Biochemical basis of malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1974-05-04

3.  Malignant hyperpyrexia. Further muscle studies in asymptomatic carriers identified by creatinine phosphokinase screening.

Authors:  H Isaacs; M B Barlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

4.  Malignant hyperpyrexia and Duchenne muscular dystrophy: A case report.

Authors:  S Oka; Y Igarashi; A Takagi; M Nishida; K Sato; K Nakada; K Ikeda
Journal:  Can Anaesth Soc J       Date:  1982-11

5.  Procaine in malignant hyperpyrexia.

Authors:  R F Moulds; M A Denborough
Journal:  Br Med J       Date:  1972-12-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.